Literature DB >> 15385131

Reoperation for palliation of recurrent malignant bowel obstruction in ovarian carcinoma.

Bhavana Pothuri1, Larissa Meyer, Melissa Gerardi, Richard R Barakat, Dennis S Chi.   

Abstract

OBJECTIVE: While initial surgical treatment for palliation of malignant bowel obstruction is well described, data on reoperation for palliation of recurrent obstruction in ovarian carcinoma are limited. The purpose of this study was to analyze the outcome of patients undergoing reoperation for repeat bowel obstruction.
METHODS: We reviewed the records of all patients with ovarian cancer who underwent repeat surgery for recurrent, malignant bowel obstruction at our institution between 1994 and 2002.
RESULTS: Ten patients were identified. All patients had bowel obstruction caused by recurrent ovarian carcinoma and had a previous corrective surgical procedure for malignant bowel obstruction. The mean age at diagnosis of repeat obstruction was 54.1 years (range, 34-74 years). All patients had initial stage III or IV disease with moderately to poorly differentiated cancers. No patient received prior radiation therapy. The sites of obstruction in patients were as follows: small bowel, 3; large bowel, 3; both small and large bowel, 4. The mean number of prior laparotomies was 2.7 (range, 2-5). The mean interval from previous surgery for bowel obstruction to recurrent bowel obstruction was 8.3 months (range, 1-22 months). Surgical correction was possible in 5 (50%) of 10 patients, with 3 (60%) of these 5 patients obtaining successful palliation. Successful palliation is defined as the ability to tolerate a regular or low-residue diet at least 60 days postoperatively. Complications included enterocutaneous fistulas in three patients (two had enterotomies at time of surgery) and wound infection in one patient. There were no postoperative mortalities. The mean postoperative stay was 15.8 days (range, 8-29 days). Two of the three patients successfully palliated presented with a subsequent obstruction at 3 and 5 months postoperatively and were treated with gastrostomy tubes. The median length of survival for the entire cohort from the date of surgery for repeat obstruction was 4.5 months (range, 3-17 months).
CONCLUSIONS: Patients undergoing repeat surgery for recurrent bowel obstruction have a low likelihood of successful palliation (30%). The surgery is associated with significant complications after surgery, rapid development of subsequent bowel obstructions, and limited survival rates. Alternative management approaches such as percutaneous endoscopic gastrostomy (PEG) tube placement should be considered in this group of patients.

Entities:  

Mesh:

Year:  2004        PMID: 15385131     DOI: 10.1016/j.ygyno.2004.07.028

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  11 in total

Review 1.  Surgery for the resolution of symptoms in malignant bowel obstruction in advanced gynaecological and gastrointestinal cancer.

Authors:  Sarah E Cousins; Emma Tempest; David J Feuer
Journal:  Cochrane Database Syst Rev       Date:  2016-01-04

Review 2.  The role of palliative surgery in gynecologic cancer cases.

Authors:  Joanie Mayer Hope; Bhavana Pothuri
Journal:  Oncologist       Date:  2013-01-08

3.  Outcomes of palliative bowel surgery for malignant bowel obstruction in patients with gynecological malignancy.

Authors:  Tomoko Goto; Masashi Takano; Tadashi Aoyama; Morikazu Miyamoto; Akio Watanabe; Masafumi Kato; Naoki Sasaki; Junko Hirata; Hidenori Sasa; Kenichi Furuya
Journal:  Oncol Lett       Date:  2012-07-30       Impact factor: 2.967

4.  Palliative care in patients with ovarian cancer and bowel obstruction.

Authors:  Alberto Daniele; A Ferrero; L Fuso; M Mineccia; V Porcellana; D Vassallo; N Biglia; G Menato
Journal:  Support Care Cancer       Date:  2015-03-25       Impact factor: 3.603

5.  Treatment Patterns, Outcomes, and Costs for Bowel Obstruction in Ovarian Cancer.

Authors:  Rudy S Suidan; Weiguo He; Charlotte C Sun; Hui Zhao; Lois M Ramondetta; Brian D Badgwell; Diane C Bodurka; Karen H Lu; Sharon H Giordano; Larissa A Meyer
Journal:  Int J Gynecol Cancer       Date:  2017-09       Impact factor: 3.437

6.  Reoperation for small bowel obstruction--how critical is the timing?

Authors:  Joseph C Carmichael; Steven Mills
Journal:  Clin Colon Rectal Surg       Date:  2006-11

Review 7.  Decompressive percutaneous gastrostomy tube use in gynecologic malignancies.

Authors:  Larissa Meyer; Bhavana Pothuri
Journal:  Curr Treat Options Oncol       Date:  2006-03

Review 8.  Treating nausea and vomiting in palliative care: a review.

Authors:  Paul Glare; Jeanna Miller; Tanya Nikolova; Roma Tickoo
Journal:  Clin Interv Aging       Date:  2011-09-12       Impact factor: 4.458

9.  Percutaneous endoscopic gastrostomy tube placement for end-stage palliation of malignant gastrointestinal obstructions.

Authors:  Anouar Teriaky; Jamie Gregor; Nilesh Chande
Journal:  Saudi J Gastroenterol       Date:  2012 Mar-Apr       Impact factor: 2.485

Review 10.  Malignant Bowel Obstruction in Advanced Gynecologic Cancers: An Updated Review from a Multidisciplinary Perspective.

Authors:  Yeh Chen Lee; Nazlin Jivraj; Catherine O'Brien; Tanya Chawla; Eran Shlomovitz; Sarah Buchanan; Jenny Lau; Jennifer Croke; Johane P Allard; Preeti Dhar; Stephane Laframboise; Sarah E Ferguson; Neesha Dhani; Marcus Butler; Pamela Ng; Terri Stuart-McEwan; Pamela Savage; Lisa Tinker; Amit M Oza; Stephanie Lheureux
Journal:  Obstet Gynecol Int       Date:  2018-05-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.